Literature DB >> 8102044

Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation.

M I Schwarz1, R L Mortenson, T V Colby, J A Waldron, D A Lynch, M P Hutt, R M Cherniack, T E King.   

Abstract

We report two patients with systemic necrotizing vasculitis (microscopic polyarteritis) and associated recurrent pulmonary capillaritis, in whom progressive irreversible airway dysfunction began approximately 10 yr after disease onset. Their course was characterized by repeated episodes of diffuse alveolar hemorrhage, glomerulonephritis, palpable purpura, and splinter hemorrhages. The lung revealed intraalveolar hemorrhage, neutrophilic infiltration and cellular fragmentation, fibrinoid necrosis of the alveolar interstitium, and parenchymal hemosiderin deposits. No medium-sized vessel involvement, granulomatous inflammation, or bronchiolar obliteration were seen. Renal biopsies revealed focal segmental necrotizing glomerulonephritis, and a cutaneous biopsy in one case showed a leukocytoclastic vasculitis. Immunofluorescent studies of lung and kidney showed minimal or no immunoreactivity. The clinical course and serologic tests did not support another systemic vasculitis, connective tissue disease, or antiglomerular basement membrane antibody disease. The acute episodes responded to antiinflammatory and immunosuppressive therapy. Symptoms, serial pulmonary function tests, and chest imaging documented the development of a progressive irreversible obstructive airway disease. No other predisposing factors were identified. These cases demonstrate the unexpected appearance of an irreversible obstructive airway disease with lung parenchymal hyperinflation after systemic necrotizing vasculitis associated with recurrent pulmonary capillaritis and diffuse alveolar hemorrhage.

Entities:  

Mesh:

Year:  1993        PMID: 8102044     DOI: 10.1164/ajrccm/148.2.507

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  Imaging of macrophage-related lung diseases.

Authors:  Katharina Marten; David M Hansell
Journal:  Eur Radiol       Date:  2005-01-05       Impact factor: 5.315

Review 3.  The pulmonary physician in critical care * illustrative case 3: pulmonary vasculitis.

Authors:  M Griffith; S Brett
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

4.  Fibrosing vasculitis in Wegener's granulomatosis: ultrastructural and immunohistochemical analysis of the vascular lesions.

Authors:  D Gindre; S Peyrol; M Raccurt; P Sommer; R Loire; J A Grimaud; J F Cordier
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Granulomatosis with polyangiitis and associated pulmonary emphysema: Breathtaking vasculitis.

Authors:  Shruti K Gadre; James K Stoller; Atul C Mehta
Journal:  Lung India       Date:  2015 Jul-Aug

6.  Pulmonary Low Attenuation Areas on CT in ANCA-associated Vasculitis: A quantitative and semi-quantitative analysis correlated with pulmonary function testing for obstructive airway disease.

Authors:  Christian W Cox; Brian J Bartholmai; Misbah Baqir; Jennifer R Geske; Ulrich Specks
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-12-16       Impact factor: 0.670

7.  KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome.

Authors:  Yoshiko Kida; Shinichiro Ohshimo; Kohei Ota; Tomoko Tamura; Tadatsugu Otani; Kazunobu Une; Takuma Sadamori; Yasumasa Iwasaki; Francesco Bonella; Noboru Hattori; Nobuyuki Hirohashi; Josune Guzman; Ulrich Costabel; Nobuoki Kohno; Koichi Tanigawa
Journal:  Orphanet J Rare Dis       Date:  2012-12-17       Impact factor: 4.123

8.  Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema.

Authors:  Argyris Tzouvelekis; George Zacharis; Anastasia Oikonomou; Dimitrios Mikroulis; George Margaritopoulos; Anastasios Koutsopoulos; Antonis Antoniadis; Andreas Koulelidis; Paschalis Steiropoulos; Panagiotis Boglou; Matina Bakali; Marios Froudarakis; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2013-05-22       Impact factor: 3.317

9.  Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults.

Authors:  Anna Stainer; Alex Rice; Anand Devaraj; Joseph Luke Barnett; Jacqueline Donovan; Maria Kokosi; Andrew Gordon Nicholson; Tom Cairns; Athol Umfrey Wells; Elisabetta Augusta Renzoni
Journal:  BMC Pulm Med       Date:  2019-10-24       Impact factor: 3.320

Review 10.  Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.

Authors:  Sarah Abramson Stoots; Lindsay Lief; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2019-09-06       Impact factor: 4.592

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.